MANAGEMENT

Prior to co-founding twoXAR, Andrew held Chief Technology Officer roles at several early stage companies where he managed teams as large as a hundred technologists distributed around the world. Andrew developed the company's proprietary algorithm and as Chief Executive Officer is focused on overall company strategy, product development and fundraising. Andrew studied biomedical informatics in Stanford University's SCPD graduate program and holds Master of Science and Bachelor of Science degrees in Computer Science from Rochester Institute of Technology.

Mark Eller brings 30 years of pharmaceutical R&D experience, including VP/SVP roles leading teams from discovery through approval. Mark’s previous experience encompasses both large (Quintiles, HMR/Sanofi predecessors) and small-to-midsize (Jazz Pharmaceuticals) pharma companies spanning a broad range of therapeutic areas. Mark is co-inventor on 30 patents and has led health authority presentations and negotiations, including 6 FDA advisory committee meetings. He has co-authored numerous scientific publications and served as an Adjunct Professor of Pharmaceutics at the University of Cincinnati. Mark received his Pharmacy degree and Ph.D. in Pharmaceutics from the University of Iowa.

Anjali Pandey is an executive leader with 25+ years of experience in CSO/SVP roles through all stages of discovery through launch. Anjali previously served as SVP of Medicinal Chemistry & Chemical Development at Portola Pharmaceuticals, where she managed discovery and CMC for Bevyxxa™ and Cerdulatinib. Most recently, Anjali held CSO/EVP positions at BridgeBio Pharma subsidiaries TheRas, Inc. and Ferro Therapeutics. Dr. Pandey has published 45+ scientific publications and is inventor on 60 issued U.S. patents. She holds an MS from the Indian Institute of Technology, a PhD from Southern Illinois University, and completed her postdoctoral fellowship at SRI International.

Allen Poirson’s previous experience includes serving as Chief Executive Officer for Sony Biotechnology, a company that develops and manufactures instruments and reagents used for researching and developing pharmaceuticals. Most recently, Allen was a Partner at Mighty Capital, a Silicon Valley-based venture capital firm, where he was responsible for investments in digital health, life science, and medical companies. Allen has formal scientific training in neuroscience and has held research positions at Howard Hughes Medical Institute and NASA. Dr. Poirson obtained his PhD and BA from Stanford University.

Aaron Daugherty is the Vice President of Discovery at twoXAR. One of twoXAR's first employees, Aaron has helped build twoXAR's drug discovery AI and leads the Discovery Science team's efforts to discover potential treatments across a wide range of diseases. Aaron earned his PhD in Genetics from Stanford University. Prior to his time at Stanford, Aaron was a Fulbright Scholar and received his Bachelor of Science in Biology from the University of Richmond.

Prior to joining twoXAR, Brian held Vice President–level positions at leading technology companies including Hewlett-Packard and Sun Microsystems in the Finance, Human Resources, and Corporate Development functions. Prior to his work in industry, Brian advised clients as an investment banker. Throughout his deal-making career, Brian has closed more than 50 deals constituting more than $15 billion in transaction value. Brian holds an MBA from Kellogg School of Management at Northwestern University where he was awarded the F.C. Austin Scholarship and a BA from University of California at Davis where he majored in English and Economics.